Displaying 1–25 of 80 results for Patheon
Five leaders from the industry join Putman’s inaugural class of winners
Mastering the complexity of PLGA microsphere manufacturing by Daniel Leblanc, Senior Vice President of CMC Operations, Flexion Therapeutics, Inc.
The integration of scientific rationale supports the probabilistic modeling approach that is required for effective QbD implementation
Why M&A may dominate the 2018 biopharma contract manufacturing landscape and the future may depend on the industry’s response to consolidation.
Contract Manufacturing & Development's Big Pharma Ascendency
The underlying drivers for CDMO Industry developments and what they mean for the pharma industry as a whole
Thermo Fisher officially acquired Patheon for $7.2 billion, entering the CDMO arena serving the pharmaceutical and biotechnology sectors
Patheon provides entry into the high-growth CDMO market and expands Thermo Fisher's biopharma services
The industry’s oldest drug form proves it’s here to stay
Once biopharma companies optimize operations in order to free up hidden capacity, they have four options: build, acquire, partner or face the realities of outsourcing
Patheon Acquires Roche API Manufacturing Site. A major supply agreement with Roche accompanies the acquisition of the Florence, South Carolina, site.
Many new facilities are designed for flexibility, combined with low-cost, highly efficient manufacturing
Serialization looms large as new technologies prove to be worth their salt
Pharma’s top CMOs are playing to their strengths, toning operations and flexing their technical muscles in an effort to compete
Market’s robust in 2015, but for how much longer?
The acquisition broadens the company's presence, product portfolio and customer network in Mexico
DPx has been busy making itself Pharma’s best CMO dance partner — one that knows all the steps
When it comes to drug development and commercialization, Contract Pharma is bringing the brains and the brawn to do Pharma’s heavy lifting
Heard it on DCAT Street: Pharma leadership talks strategy at one of the industry’s oldest gatherings
Pharmaceutical processors have begun to wield some new tools, nailing down new efficiencies and better drugs in the process
Gaining both mass and velocity, Biopharma is an industry on the move
DPx Holdings B.V, the result of a $2.65 billion transaction between JLL Partners and Royal DSM finalized in March, has completed the transaction to acquire Gallus BioPharmaceuticals, LLC, a leading St. Louis-based contract manufacturing company specializing in biologics.
Glass and plastic are Pharma packaging’s superheroes, but while they are rivals, they continue to develop their respective technical and material attributes to cope with the ever-changing pharmaceutical manufacturing landscape in an effort to win the hearts and minds of drug makers and help fight...
This white paper discusses the roles of sponsors and their contract manufacturing organization (CMO) partners regarding metrics, what metrics to measure, how to manage data, effective communications and ownership, and ways to improve metrics.